[Antitumor immunity in mice bearing sarcoma 180 after treatment with the combination of diazoacetylglycine hydrazide and 5-fluorouracil].
D000818:Animals; D005472:Fluorouracil / Q000627:therapeutic use*; D006834:Hydrazines / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D051379:Mice; D009365:Neoplasm Regression, Spontaneous; D012510:Sarcoma 180 / Q000188:drug therapy / Q000276:immunology*
D006834:Hydrazines; D007166:Immunosuppressive Agents; D005472:Fluorouracil
Immunita' antitumorale in topi portatori di sarcoma 180 dopo trattamento con assozione di diazoacetilglicina idrazide e 5-fluorouracile.